Eli Lilly & Company (NYSE:LLY) ranks among the stocks with the best earnings growth for the next 5 years. Cantor Fitzgerald reaffirmed its Overweight rating and $925 price target for Eli Lilly & ...

Healthcare stocks can provide growth and consistent returns through a variety of market cycles. Eli Lilly has a storied ...

Or how about the drug companies? Holy cow, remember them? They used to be big and important, weren’t they? Eli Lilly reported this morning, and their GLP-1 complex, you know, the weight loss ...

South Korean tech giant Samsung is making a major investment in artificial intelligence by building a factory powered by 50,000 Nvidia GPUs. This AI megafactory, as Samsung calls it, aims to ...

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the ...

Berkshire reported $13.485 billion in operating profit from its wholly owned businesses in the third quarter, a 34% increase ...

The stock market has continued to climb, but it's been tricky. Palantir, Robinhood and AMD lead big earnings this week.

Virginia will be home to a workforce training center preparing thousands of people each year for a career in the pharmaceutical industry.

Walmart Pharmacies to offer weight-loss drug making obesity treatment more accessible for millions nationwide.

Novo Nordisk made a surprise bid for Metsera to boost its weight-loss market lead, trading at just 12x 2026 EPS. Read why NVO stock is a buy.

Pfizer is suing Novo Nordisk following the Danish pharma's last-minute bid to acquire Metsera, which Pfizer called “reckless”.

Accelerated returns have been common over the last few years, as powerful tech trends like artificial intelligence (AI) ...